🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/06/2021 85,94 90,60 85,81 89,81 +4,87% 5,57% 856.500
18/06/2021 85,03 86,71 84,51 85,64 -0,40% 2,59% 1.264.600
17/06/2021 85,44 86,93 84,93 85,98 +0,16% 2,34% 532.700
16/06/2021 86,65 87,36 83,89 85,84 -0,91% 4,01% 623.000
15/06/2021 88,59 89,17 85,72 86,63 -2,01% 3,89% 741.800
14/06/2021 88,00 89,77 87,52 88,41 -0,34% 2,56% 685.100
11/06/2021 86,72 90,64 86,40 88,71 +5,96% 4,89% 1.568.300
10/06/2021 81,70 84,41 80,80 83,72 +2,33% 4,42% 718.800
09/06/2021 81,86 82,86 81,10 81,81 +0,89% 2,15% 779.600
08/06/2021 80,71 81,83 78,42 81,09 +0,51% 4,22% 685.400
07/06/2021 76,29 81,52 76,19 80,68 +5,96% 6,98% 882.900
04/06/2021 72,93 76,37 72,76 76,14 +4,99% 4,95% 724.100
03/06/2021 72,37 72,84 71,03 72,52 +0,39% 2,50% 848.500
02/06/2021 71,75 72,33 71,22 72,24 +0,46% 1,55% 1.251.100
01/06/2021 72,51 73,51 71,59 71,91 -0,95% 2,65% 904.000
28/05/2021 73,19 74,40 72,36 72,60 -0,23% 2,79% 961.500
27/05/2021 74,06 74,06 72,41 72,77 -0,95% 2,23% 1.149.500
26/05/2021 74,66 74,66 72,60 73,47 -0,54% 2,76% 418.400
25/05/2021 75,23 76,64 73,49 73,87 -1,30% 4,19% 581.000
24/05/2021 75,17 75,26 74,10 74,84 +0,82% 1,54% 451.400
21/05/2021 75,59 75,99 73,82 74,23 -0,68% 2,87% 370.600
20/05/2021 72,11 76,02 71,99 74,74 +4,65% 5,58% 721.400
19/05/2021 70,45 72,36 70,06 71,42 -1,16% 3,26% 729.600
18/05/2021 73,93 75,26 72,13 72,26 -1,08% 4,23% 521.500
17/05/2021 72,32 73,95 70,56 73,05 +0,30% 4,69% 591.200
14/05/2021 68,43 74,13 68,00 72,83 +7,29% 8,95% 695.600
13/05/2021 69,39 69,91 65,92 67,88 -1,19% 5,75% 688.900
12/05/2021 68,44 70,51 68,22 68,70 -1,59% 3,35% 636.800
11/05/2021 64,15 71,11 63,50 69,81 +5,61% 11,86% 781.800
10/05/2021 65,95 67,29 64,42 66,10 -0,42% 4,35% 817.800